1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cystic fibrosis

Colistimethate sodium and tobramycin dry powders for inhalation for treating pseudomonas lung infection in cystic fibrosis

Technology appraisal guidance [TA276] Published: 27 March 2013

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Evidence

Review and download supporting evidence. Includes the full guideline if available.

Supporting evidence

  • Review decision  
  • Review Decision – October 2015  
  • Appendix A - RPP decision paper - October 2015 PDF 17 KB 19 October 2015